I

iBio
D

IBIO

2.51000
USD
0.03
(1.21%)
مغلق
حجم التداول
20
الربح لكل سهم
-8
العائد الربحي
-
P/E
-10
حجم السوق
22,965,170
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABEO
    0.05000
    (0.89%)
    5.68000 USD
    A
    ABMD
    0
    (0%)
    0.000000 USD
    A
    ACER
    0
    (0%)
    0.000000 USD
    A
    ACRS
    -0.03500
    (-1.27%)
    2.73000 USD
    A
    ADAP
    0.00500
    (0.84%)
    0.59970 USD
    A
    ADC
    0.750
    (1.08%)
    70.210 USD
    ALNY
    ALNY
    6.675
    (2.79%)
    245.505 USD
    B
    BCLI
    0.23000
    (11.33%)
    2.26000 USD
    المزيد
الأخبار

العنوان: iBio

القطاع: Healthcare
الصناعة: Biotechnology
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.